Pharmacists ‘perfectly placed’ to deliver nationally commissioned weight-loss service, MPs told Attendees of the Health and Social Care Committee session emphasised the importance of “wrap-around care” alongside prescribing GLP-1 medicines.…
Pharmacy research: driving safer outcomes in substance misuse Research offers a crucial opportunity in shaping healthcare policy and practice, particularly in the developing landscape of substance misuse.…
Test your knowledge of musculoskeletal conditions Our self-assessment quiz on musculoskeletal conditions covers the more common disorders that pharmacy staff may encounter, from arthritis and gout to carpal tunnel syndrome.…
Coroner calls for greater recognition of clinical significance of ‘excessive’ salbutamol inhaler use A patient died in December 2023 after using an salbutamol inhaler more than frequently than recommended.…
Health news round-up: Alzheimer’s treatment, retatrutide results and kidney cancer guidelines A weekly summary of important developments in pharmacy and health news that you may have missed.…
Apixaban safer than rivaroxaban for thrombosis treatment, study finds Researchers found that patients who took anticoagulant apixaban for the treatment of venous thrombosis experienced less “clinically relevant bleeding”, compared with those who received rivaroxaban.…
It is ‘vital’ that patients access weight-loss jabs from pharmacies, says London health committee A report by the London Assembly Health Committee recommended strict safeguards to ensure that only the eligible can purchase weight-loss drugs, as well as comprehensive wrap-around care for patients.…
London’s first drug-checking service could expand to more cities Under the drug-checking service, users can submit substances for testing and will subsequently receive “anonymous, non-judgemental chat”, alongside tailored harm reduction advice.…
Government pledges support for more safer drug consumption facilities in ten-year alcohol and drug strategy The Scottish government's alcohol and drugs strategic plan for 2026–2035 also sets out plans to further expand the distribution of naloxone, including through community pharmacies.…
JAK inhibitors: risks and safety principles An overview of the mechanism of action of Janus kinase inhibitors, as well as the risks and common side effects of their use in treating chronic inflammatory disorders.…
